Onvin 8 Not available

Indication

Onvin 8 (Ondansetron) is a selective serotonin 5-HT3 receptor antagonist used for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and post-operative procedures.

Ingredients

• Ondansetron 8 mg

Direction

Adults: 8 mg given orally 1–2 hours before chemotherapy or surgery, followed by 8 mg after 8 hours, then 8 mg every 12 hours for 1–2 days. Post-operative nausea: 16 mg orally 1 hour before surgery. Dose as directed by physician.

Side effects

• Headache
• constipation.
• Flushing
• dizziness.
• Rare: QT prolongation
• hypersensitivity reactions.

Precautions

• Use with caution in patients with known QT prolongation or electrolyte abnormalities.
• Avoid concomitant use with other QT
• prolonging drugs.
• Use with caution in patients with severe hepatic impairment.
• Keep out of reach of children.